These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 36539781)

  • 1. Patient-reported outcomes in terms of swallowing and quality of life after prophylactic versus reactive percutaneous endoscopic gastrostomy tube placement in advanced oropharyngeal cancer patients treated with definitive chemo-radiotherapy: Swall PEG study.
    Dragan T; Van Gossum A; Duprez F; Lalami Y; Lefebvre Y; Mootassim-Billah S; Beauvois S; Gulyban A; Vandekerkhove C; Boegner P; Paesmans M; Ameye L; Digonnet A; Quiriny M; Dequanter D; Lipski S; Willemse E; Rodriguez A; Carlot S; Karaca Y; Lemort M; Emonts P; Al Wardi C; Van Gestel D
    Trials; 2022 Dec; 23(1):1036. PubMed ID: 36539781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Swallowing outcomes for patients with oropharyngeal squamous cell carcinoma treated with primary (chemo)radiation therapy receiving either prophylactic gastrostomy or reactive nasogastric tube: A prospective cohort study.
    Goff D; Coward S; Fitzgerald A; Paleri V; Moor JW; Patterson JM
    Clin Otolaryngol; 2017 Dec; 42(6):1135-1140. PubMed ID: 28128886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxicities and costs of placing prophylactic and reactive percutaneous gastrostomy tubes in patients with locally advanced head and neck cancers treated with chemoradiotherapy.
    Baschnagel AM; Yadav S; Marina O; Parzuchowski A; Lanni TB; Warner JN; Parzuchowski JS; Ignatius RT; Akervall J; Chen PY; Krauss DJ
    Head Neck; 2014 Aug; 36(8):1155-61. PubMed ID: 23852670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of prophylactic gastrostomy or reactive NG tube upon patient-reported long term swallow function following chemoradiotherapy for oropharyngeal carcinoma: A matched pair analysis.
    Sethugavalar B; Teo MT; Buchan C; Ermiş E; Williams GF; Sen M; Prestwich RJD
    Oral Oncol; 2016 Aug; 59():80-85. PubMed ID: 27424186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Routine Prophylactic Percutaneous Endoscopic Gastrostomy in Head and Neck Cancers with Bilateral Neck Irradiation: A Regional Cancer Experience in New Zealand.
    Fong SC; Pandey R; Rajaretnam M; Delaibatiki M; Peel DNY
    J Med Radiat Sci; 2023 Sep; 70(3):292-300. PubMed ID: 37403761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for percutaneous endoscopic gastrostomy tube placement during chemoradiotherapy for oropharyngeal cancer.
    Strom T; Trotti AM; Kish J; Rao NG; McCaffrey J; Padhya TA; Lin HY; Fulp W; Caudell JJ
    JAMA Otolaryngol Head Neck Surg; 2013 Nov; 139(11):1242-6. PubMed ID: 24136493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylactic versus reactive gastrostomy tube placement in advanced head and neck cancer treated with definitive chemoradiotherapy: A systematic review.
    McClelland S; Andrews JZ; Chaudhry H; Teckie S; Goenka A
    Oral Oncol; 2018 Dec; 87():77-81. PubMed ID: 30527247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The PRO-ACTIVE trial protocol: a randomized study comparing the effectiveness of PROphylACTic swallow InterVEntion for patients receiving radiotherapy for head and neck cancer.
    Martino R; Fitch MI; Fuller CD; Hope A; Krisciunas G; Langmore SE; Lazarus C; Macdonald CL; McCulloch T; Mills G; Palma DA; Pytynia K; Ringash J; Sultanem K; Theurer J; Thorpe KE; Hutcheson K
    BMC Cancer; 2021 Oct; 21(1):1100. PubMed ID: 34645411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of prophylactic percutaneous endoscopic gastrostomy (PEG) tube placement on swallowing and swallow-related outcomes in patients undergoing radiotherapy for head and neck cancer: a systematic review.
    Shaw SM; Flowers H; O'Sullivan B; Hope A; Liu LW; Martino R
    Dysphagia; 2015 Apr; 30(2):152-75. PubMed ID: 25737196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association Between Objective Ratings of Swallowing and Dysphagia-Specific Quality of Life in Patients Receiving (Chemo)radiotherapy for Oropharyngeal Cancer.
    Wishart LR; Harris GB; Cassim N; Alimin S; Liao T; Brown B; Ward EC; Nund RL
    Dysphagia; 2022 Aug; 37(4):1014-1021. PubMed ID: 34625841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Nutritional and Clinical Outcomes in Patients with Head and Neck Cancer Undergoing Chemoradiotherapy Utilizing Prophylactic versus Reactive Nutrition Support Approaches.
    Brown TE; Banks MD; Hughes BGM; Lin CY; Kenny LM; Bauer JD
    J Acad Nutr Diet; 2018 Apr; 118(4):627-636. PubMed ID: 27986517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DARS: a phase III randomised multicentre study of dysphagia- optimised intensity- modulated radiotherapy (Do-IMRT) versus standard intensity- modulated radiotherapy (S-IMRT) in head and neck cancer.
    Petkar I; Rooney K; Roe JW; Patterson JM; Bernstein D; Tyler JM; Emson MA; Morden JP; Mertens K; Miles E; Beasley M; Roques T; Bhide SA; Newbold KL; Harrington KJ; Hall E; Nutting CM
    BMC Cancer; 2016 Oct; 16(1):770. PubMed ID: 27716125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastrostomy tube placement in patients with oropharyngeal carcinoma treated with radiotherapy or chemoradiotherapy: factors affecting placement and dependence.
    Bhayani MK; Hutcheson KA; Barringer DA; Lisec A; Alvarez CP; Roberts DB; Lai SY; Lewin JS
    Head Neck; 2013 Nov; 35(11):1634-40. PubMed ID: 23322563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PATHOS: a phase II/III trial of risk-stratified, reduced intensity adjuvant treatment in patients undergoing transoral surgery for Human papillomavirus (HPV) positive oropharyngeal cancer.
    Owadally W; Hurt C; Timmins H; Parsons E; Townsend S; Patterson J; Hutcheson K; Powell N; Beasley M; Palaniappan N; Robinson M; Jones TM; Evans M
    BMC Cancer; 2015 Aug; 15():602. PubMed ID: 26311526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive Factors for Prophylactic Percutaneous Endoscopic Gastrostomy (PEG) Tube Placement and Use in Head and Neck Patients Following Intensity-Modulated Radiation Therapy (IMRT) Treatment: Concordance, Discrepancies, and the Role of Gabapentin.
    Yang W; McNutt TR; Dudley SA; Kumar R; Starmer HM; Gourin CG; Moore JA; Evans K; Allen M; Agrawal N; Richmon JD; Chung CH; Quon H
    Dysphagia; 2016 Apr; 31(2):206-13. PubMed ID: 26753929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of prophylactic swallowing exercises on dysphagia and quality of life in patients with head and neck cancer receiving (chemo) radiotherapy: the Redyor study, a protocol for a randomized clinical trial.
    Guillen-Sola A; Soler NB; Marco E; Pera-Cegarra O; Foro P
    Trials; 2019 Aug; 20(1):503. PubMed ID: 31412947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylactic versus reactive PEG tube placement in head and neck cancer.
    Kramer S; Newcomb M; Hessler J; Siddiqui F
    Otolaryngol Head Neck Surg; 2014 Mar; 150(3):407-12. PubMed ID: 24381015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of prophylactic percutaneous endoscopic gastrostomy tube on swallowing in advanced head and neck cancer: A randomized controlled study.
    Axelsson L; Silander E; Nyman J; Bove M; Johansson L; Hammerlid E
    Head Neck; 2017 May; 39(5):908-915. PubMed ID: 28152219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multi-institution pooled analysis of gastrostomy tube dependence in patients with oropharyngeal cancer treated with definitive intensity-modulated radiotherapy.
    Setton J; Lee NY; Riaz N; Huang SH; Waldron J; O'Sullivan B; Zhang Z; Shi W; Rosenthal DI; Hutcheson KA; Garden AS
    Cancer; 2015 Jan; 121(2):294-301. PubMed ID: 25286832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic exercises for affecting post-treatment swallowing in people treated for advanced-stage head and neck cancers.
    Perry A; Lee SH; Cotton S; Kennedy C
    Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD011112. PubMed ID: 27562477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.